However, many patients report feeling fuller after meals and experiencing fewer cravings, which sets the stage for gradual weight loss in the coming weeks
In some cases, it is recommended to inject once a week
STEP 1 to STEP 3 clinical trial data show that 6-7% of patients discontinued semaglutide treatment due to side effects compared to 3 to 4% patients in the placebo group
Clinical Topics: Arrhythmias and Clinical EP, COVID-19 Hub, Heart Failure and Cardiomyopathies, Noninvasive Imaging, Atrial Fibrillation/Supraventricular Arrhythmias, Acute Heart Failure, Echocardiography/Ultrasound Keywords: ESC Congress, ESC24, Diabetes Mellitus, Type 2, Atrial Fibrillation, Heart Failure, COVID-19, Obesity, Echocardiography
Cost and accessibility Semaglutide can be expensive, and insurance coverage varies, making long-term use challenging